Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Kevin R. Bainey, MD"'
Autor:
Laurie-Anne Boivin-Proulx, MD, MSc, Kevin R. Bainey, MD, MSc, Guillaume Marquis-Gravel, MD, Michelle M. Graham, MD
Publikováno v:
CJC Open, Vol 6, Iss 5, Pp 677-688 (2024)
Background: Balancing the effects of dual antiplatelet therapy (DAPT) in the era of potent purinergic receptor type Y, subtype 12 (P2Y12) inhibitors remains a challenge in the management of acute coronary syndrome (ACS). Methods: We conducted a syste
Externí odkaz:
https://doaj.org/article/8d6613b567574ab4a5ae19db4d8361f7
Autor:
Ahmad Hayek, MD, Blair J. MacDonald, BA PharmD, Guillaume Marquis-Gravel, MD, MSc, Kevin R. Bainey, MD, MSc, Samer Mansour, MD, Margaret L. Ackman, PharmD, Warren J. Cantor, MD, Ricky D. Turgeon, BSc(Pharm), PharmD
Publikováno v:
CJC Open, Vol 6, Iss 5, Pp 708-720 (2024)
Background: Ongoing debate remains regarding optimal antithrombotic therapy in patients with atrial fibrillation (AF) and coronary artery disease. Methods: We performed a systematic review and meta-analysis to synthesize randomized controlled trials
Externí odkaz:
https://doaj.org/article/64896edc917548ddace1fecbe9a31191
Autor:
Chloë Laferrière, MD, Chloé Moazzami, MD, Emilie Belley-Côté, MD, PhD, Kevin R. Bainey, MD, MSc, Guillaume Marquis-Gravel, MD, MSc, Alexa Fama, Marie Lordkipanidzé, BPharm, PhD, Brian J. Potter, MDCM, SM
Publikováno v:
CJC Open, Vol 5, Iss 12, Pp 881-890 (2023)
Background: Since the publication of the 2010 Canadian antiplatelet guidelines, several large randomized controlled trials (RCTs) have evaluated the role of aspirin (ASA) use in primary prevention. We evaluated the effect of ASA use, compared with no
Externí odkaz:
https://doaj.org/article/7ba80420a7ea47b4a3bf965d05b3e0e4
Autor:
Felipe H. Valle, MD, PhD, Shaun G. Goodman, MD, MSc, Mary Tan, MSc, Andrew Ha, MD, Samer Mansour, MD, Robert C. Welsh, MD, Andrew T. Yan, MD, Kevin R. Bainey, MD, MSc, Stephane Rinfret, MD, Brian J. Potter, MDCM SM, Razi Khan, MD, Gerald Simkus, MD, Madhu K. Natarajan, MD, J.D. Schwalm, MD, Benoit Daneault, MD, Mark J. Eisenberg, MD, MPH, Joseph Abunassar, MD, Bryan Har, MD, MPH, Jean Gregoire, MD, Jean-Francois Tanguay, MD, Christopher B. Overgaard, MD, Jean-Pierre Dery, MD, Robert De Larochelliere, MD, Jean-Michel Paradis, MD, Mina Madan, MD, MHS, Basem Elbarouni, MBBCh, Derek Y.F. So, MD, Ata-Ur-Rehman Quraishi, MBBS, Akshay Bagai, MD, MHS
Publikováno v:
CJC Open, Vol 3, Iss 12, Pp 1419-1427 (2021)
Background: In patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI), selecting an antithrombotic regimen requires balancing risks of ischemic cardiac events, stroke, and bleeding. Methods: We studied 467 patients
Externí odkaz:
https://doaj.org/article/eb37fce9ac584e069aa2601948f5239b
Autor:
Kevin R. Bainey, MD, MSc, Ahmed Abulhamayel, MD, Amir Aziz, MRCP, PhD, Harald Becher, MD, PhD
Publikováno v:
CJC Open, Vol 4, Iss 7, Pp 644-646 (2022)
Reperfusion injury is common following primary percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction. In a prospective Canadian single-arm study of 15patients, the use of myocardial contrast echocardiography with high mechani
Externí odkaz:
https://doaj.org/article/86bfb47558214ffb874410590a19cd65
Autor:
Stéphane Rinfret, MD, SM, Israth Jahan, BSc, Kevin McKenzie, Nandini Dendukuri, PhD, Kevin R. Bainey, MD, MSc, Samer Mansour, MD, Madhu Natarajan, MD, Luiz F. Ybarra, MD, PhD, MBA, Aun-Yeong Chong, BSc, MBBS, MD, MRCP, Simon Bérubé, MD, Robert Breton, MD, Michael J. Curtis, MD, Josep Rodés-Cabau, MD, Amlani Shy (Shoaib), MD, Alireza Bagherli, MD, Warren Ball, MD, Alan Barolet, MD, PhD, Hussein K. Beydoun, MD, Neil Brass, MD, Albert W. Chan, MD, MSc, Franco Colizza, MD, Christian Constance, MD, Neil P. Fam, MD, MSc, François Gobeil, MD, Tinouch Haghighat, MD, Steven Hodge, MD, Dominique Joyal, MD, Hahn Hoe Kim, MD, CM, Sohrab Lutchmedial, MD, Andrea MacDougall, MD, Paul Malik, MD, Steve Miner, MD, Kunal Minhas, BSc, MD, Jason Orvold, MD, Donald Palisaitis, MD, Brendan Parfrey, MD, Jean-Michel Potvin, MD, Geoffrey Puley, MD, Sam Radhakrishnan, MD, Marco Spaziano, MD, Jean-François Tanguay, MD, Ram Vijayaraghaban, MD, John G. Webb, MD, Rodney H. Zimmermann, MD, David A. Wood, James M. Brophy, MD, PhD
Publikováno v:
CJC Open, Vol 3, Iss 9, Pp 1125-1131 (2021)
Background: As a result of the COVID-19 pandemic first wave, reductions in ST-elevation myocardial infarction (STEMI) invasive care, ranging from 23% to 76%, have been reported from various countries. Whether this change had any impact on coronary an
Externí odkaz:
https://doaj.org/article/a8bf8c71b9a14374baffa5709e52ace1
Publikováno v:
CJC Open, Vol 3, Iss 7, Pp 936-949 (2021)
Due to the pathophysiology of atherosclerosis, the management for coronary artery disease and peripheral arterial disease (PAD) were considered homogenous, with therapies focused on the use of lipid-lowering medications, antiplatelet therapy, glucose
Externí odkaz:
https://doaj.org/article/b89b5c4ab11347c6a6992509064309fd
Autor:
Debraj Das, MD, MSc, Anamaria Savu, PhD, Kevin R. Bainey, MD, MSc, Robert C. Welsh, MD, Padma Kaul, PhD
Publikováno v:
CJC Open, Vol 3, Iss 4, Pp 479-487 (2021)
Background: Although ST-elevation myocardial infarction (STEMI) management has evolved substantially over the past decade, its effect on bleeding and transfusion rates are largely unknown in a contemporary population. Methods: Our study cohort includ
Externí odkaz:
https://doaj.org/article/7c56c0faf2144514835b7bcad0ed323c
Autor:
Khai-Tuan A. Bui, Alexis Matteau, MD, SM, Basem Elbarouni, MD, Kevin R. Bainey, MD, Christopher B. Fordyce, MD, Akshay Bagai, MD, Barry Rose, MD, Sohrab Lutchmedial, MD, Benjamin Leis, MD, Andrea Lavoie, MD, Jafna Cox, MD, Samer Mansour, MD, Brian J. Potter, MDCM, SM
Publikováno v:
CJC Open, Vol 2, Iss 6, Pp 619-624 (2020)
Background: Antithrombotic management following acute coronary syndromes (ACSs) has evolved significantly. However, given lingering uncertainty as to when an ACS may be considered stable, there is the possibility of practice divergence beyond the fir
Externí odkaz:
https://doaj.org/article/74030381bdb04d7a8e2deed82b030159
Autor:
Shelby L. Sluchinski, RN, MN/NP Student, Edith Pituskin, RN, MN (NP Adult), PhD, Kevin R. Bainey, MD, Colleen M. Norris, RN, BScN, MN, PhD, GNP, FAHA
Publikováno v:
CJC Open, Vol 2, Iss 5, Pp 395-401 (2020)
Myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) is reported in 6% of patients with acute MI referred for catheterization. Because of the complex etiology and a limited amount of evidence, the treatment of MINOCA remains elu
Externí odkaz:
https://doaj.org/article/436b5d315b7c407ab94b0d318d656541